Acute leukemias in children with Down syndrome.

Acute leukemias in children with Down syndrome.

عرض إصدارات أخرى (1)

Children with Down syndrome have an increased risk for developing both acute myeloid as well as lymphoblastic leukemia. These leukemias differ in presenting characteristics and underlying biology when compared with leukemias occurring in non-Down syndrome children. Myeloid leukemia in children with...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Zwaan, M, Reinhardt, D, Hitzler, J, Vyas, P
التنسيق:	Journal article
اللغة:	English
منشور في:	2008

مواد مشابهة

Acute leukemias in children with Down syndrome.
حسب: Zwaan, C, وآخرون
منشور في: (2010)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.
حسب: Maroz, A, وآخرون
منشور في: (2014)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
حسب: Maroz, A, وآخرون
منشور في: (2014)

Acute leukemia in children with Down syndrome
حسب: Ana C. Xavier, وآخرون
منشور في: (2010-07-01)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
حسب: Reinhardt, K, وآخرون
منشور في: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
حسب: Reinhardt, K, وآخرون
منشور في: (2010)

Myeloid pre-leukemia and leukemia of Down syndrome
حسب: Cruz Hernandez, D, وآخرون
منشور في: (2020)

Down syndrome preleukemia and leukemia.
حسب: Maloney, K, وآخرون
منشور في: (2014)

Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia
حسب: Trudy D. Buitenkamp, وآخرون
منشور في: (2010-07-01)

Molecular insights into Down syndrome-associated leukemia.
حسب: Vyas, P, وآخرون
منشور في: (2007)

JAK mutations in Down syndrome - associated transient myeloproliferative disorder and acute megakaryocytic leukemia
حسب: Vyas, P, وآخرون
منشور في: (2008)

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.
حسب: Hasle, H, وآخرون
منشور في: (2008)

Modelling the progression of a preleukemic stage to overt leukemia in children with down syndrome
حسب: Labuhn, M, وآخرون
منشور في: (2018)

Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study
حسب: Marius Flasinski, وآخرون
منشور في: (2018-07-01)

THE ACUTE LYMPHOBLASTIC LEUKEMIA OF DOWN SYNDROME
حسب: Cemile SELIMOGLU, وآخرون
منشور في: (2022-10-01)

Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome
حسب: Labuhn, M, وآخرون
منشور في: (2019)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
حسب: Alford, K, وآخرون
منشور في: (2011)

Acute leukemia in children with Down’s syndrome: the importance of population based study
حسب: Rebecca James, وآخرون
منشور في: (2008-08-01)

Epigenome-wide association study of acute lymphoblastic leukemia in children with Down syndrome
حسب: Li, S, وآخرون
منشور في: (2022)

Germline variants in predisposition genes in children with Down syndrome and acute lymphoblastic leukemia
حسب: Winer, P, وآخرون
منشور في: (2020)

Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations.
حسب: Buitenkamp, T, وآخرون
منشور في: (2012)

Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations
حسب: Buitenkamp, T, وآخرون
منشور في: (2012)

Treatment of acute lymphocytic leukemia in Down syndrome
حسب: Yuki Gemma, وآخرون
منشور في: (2017-01-01)

BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia.
حسب: Buitenkamp, T, وآخرون
منشور في: (2013)

BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia
حسب: Buitenkamp, T, وآخرون
منشور في: (2013)

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
حسب: Norton, A, وآخرون
منشور في: (2007)

Down syndrome and leukemia: from basic mechanisms to clinical advances
حسب: André Baruchel, وآخرون
منشور في: (2023-07-01)

Haematology of Down syndrome.
حسب: Webb, D, وآخرون
منشور في: (2007)

Features of acute megakaryoblastic leukemia diagnosis in a child with Down syndrome
حسب: N. K. Guskova, وآخرون
منشور في: (2023-03-01)

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome
حسب: Cruz Hernandez, D, وآخرون
منشور في: (2020)

Gemtuzumab ozogamicin in acute myeloid leukemia: act 2, with perhaps more to come
حسب: Johann Hitzler, وآخرون
منشور في: (2019-01-01)

Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome.
حسب: Roy, A, وآخرون
منشور في: (2012)

Acute megakaryoblastic leukaemia in Down syndrome and non-Down syndrome patients - molecular signature of a disease - subtypes with distinct treatment outcomes
حسب: Vyas, P, وآخرون
منشور في: (2007)

Acute Kidney Injury in Myeloid Leukemia of Down Syndrome: Risk Factors and Outcomes
حسب: Chompoonut Limratchapong, وآخرون
منشور في: (2023-03-01)

Molecular Mechanisms of the Genetic Predisposition to Acute Megakaryoblastic Leukemia in Infants With Down Syndrome
حسب: Juliane Grimm, وآخرون
منشور في: (2021-03-01)

Mosaic Down syndrome and acute lymphoblastic B cell-leukemia. Case report
حسب: Parra-Baltazar, Isabel Mónica, وآخرون
منشور في: (2016-10-01)

Down syndrome-like acute megakaryoblastic leukemia in a patient with Cornelia de Lange syndrome
حسب: Yoann Vial, وآخرون
منشور في: (2018-06-01)

Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia
حسب: Shannon L. Carey-Smith, وآخرون
منشور في: (2024-02-01)

GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.
حسب: Hellebostad, M, وآخرون
منشور في: (2005)

Frequency of cardiovascular and gastrointestinal malformations, leukemia and hypothyroidism in children with Down syndrome in Trabzon, Turkey
حسب: F M Aynaci, وآخرون
منشور في: (1998-01-01)